Evotec SE
EVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412558
No open-market purchases or sales by Evotec SE insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $9.07M in total; no superinvestor holds it.
Other share classesEVOTF
13F holders, Q2 2025
Institutional positions in Evotec SE as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +12 vs. Q1 2025
- Shares held
- 9.65M
- +556.3K (+6.1%) vs. Q1 2025
- Total value
- $40.5M
- +$10.1M (+33.4%) vs. Q1 2025
- New holders
- 16
- 5 more added
- Sold out
- 4
- 8 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $9.07M |
| Q1 2026 | 46 | $20.3M |
| Q4 2025 | 44 | $30.4M |
| Q3 2025 | 37 | $35.9M |
| Q2 2025 | 37 | $40.5M |
| Q1 2025 | 25 | $30.4M |
| Q4 2024 | 26 | $36.9M |
| Q3 2024 | 24 | $29.6M |
| Q2 2024 | 28 | $35.0M |
| Q1 2024 | 20 | $38.7M |
| Q4 2023 | 28 | $66.5M |
| Q3 2023 | 24 | $12.0M |
| Q2 2023 | 20 | $15.4M |
| Q1 2023 | 19 | $14.5M |
| Q4 2022 | 22 | $21.1M |
| Q3 2022 | 22 | $43.5M |
| Q2 2022 | 21 | $57.3M |
| Q1 2022 | 22 | $83.3M |
| Q4 2021 | 20 | $157.3M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Evotec SE; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Assetmark, Inc | 52 | $218 | 0.00% | +52 | New |
| SBI Securities Co., Ltd. | 97 | $407 | 0.00% | −2−2.0% | Reduced |
| Jones Financial Companies LLLP | 150 | $624 | 0.00% | 00.0% | Unchanged |
| Accent Capital Management, LLC | 200 | $840 | 0.00% | 00.0% | Unchanged |
| GAMMA Investing LLC | 212 | $890 | 0.00% | +212 | New |
| US Bancorp | 250 | $1.05K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 349 | $1.47K | 0.00% | −141−28.8% | Reduced |
| Royal Bank of Canada | 674 | $3.00K | 0.00% | +674 | New |
| Principal Securities, Inc. | 753 | $3.16K | 0.00% | +711+1,692.9% | Added |
| CBIZ Investment Advisory Services, LLC | 840 | $3.53K | 0.00% | 00.0% | Unchanged |
| Briaud Financial Planning, Inc | 2,160 | $9.00K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 2,178 | $9.15K | 0.00% | +2,178 | New |
| Signaturefd, LLC | 2,338 | $9.82K | 0.00% | −714−23.4% | Reduced |
| Goldman Sachs Group Inc | 10,054 | $42.2K | 0.00% | −1,814−15.3% | Reduced |
| Valeo Financial Advisors, LLC | 10,241 | $43.0K | 0.00% | +10,241 | New |
| UBS Group AG | 10,360 | $43.5K | 0.00% | −3,260−23.9% | Reduced |
| Wiley Bros.-Aintree Capital, LLC | 10,818 | $45.4K | 0.00% | +10,818 | New |
| BNP Paribas Arbitrage, SA | 12,000 | $50.4K | 0.00% | +4,600+62.2% | Added |
| CSS LLC | 12,100 | $50.8K | 0.00% | 00.0% | Unchanged |
| Umb Bank N A | 13,315 | $55.9K | 0.00% | +13,315 | New |
| XTX Topco Ltd | 15,597 | $65.5K | 0.00% | +15,597 | New |
| Commonwealth Equity Services, LLC | 18,250 | $77.0K | 0.00% | +18,250 | New |
| Bank of America Corp | 20,506 | $86.1K | 0.00% | +16,618+427.4% | Added |
| Snowden Capital Advisors LLC | 29,053 | $122.0K | 0.00% | +29,053 | New |
| Citadel Advisors LLC | 33,574 | $141.0K | 0.00% | +33,574 | New |
| Lighthouse Investment Partners, LLC | 37,545 | $157.7K | 0.01% | 00.0% | Unchanged |
| LPL Financial LLC | 37,845 | $158.9K | 0.00% | +37,845 | New |
| Abc Arbitrage SA | 38,960 | $163.6K | 0.02% | −38,959−50.0% | Reduced |
| Marshall Wace, LLP | 40,310 | $169.3K | 0.00% | +40,310 | New |
| Envestnet Asset Management Inc | 91,664 | $385.0K | 0.00% | +91,664 | New |
| Pitcairn Co | 261,181 | $1.10M | 0.07% | +261,181 | New |
| WCM Investment Management, LLC | 297,907 | $1.24M | 0.00% | +297,907 | New |
| Morgan Stanley | 385,214 | $1.62M | 0.00% | +297,173+337.5% | Added |
| DCF Advisers, LLC | 1,114,493 | $4.68M | 2.25% | +362,914+48.3% | Added |
| Wellington Management Group LLP | 1,205,554 | $5.06M | 0.00% | −697,847−36.7% | Reduced |
| BlackRock, Inc. | 1,340,272 | $5.63M | 0.00% | −182,392−12.0% | Reduced |
| Mubadala Investment Co PJSC | 4,597,701 | $19.3M | 0.10% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −41,185−100.0% | Sold out |
| Fore Capital, LLC | 0 | $0 | 0.00% | −17,005−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −5,300−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −4−100.0% | Sold out |